Andre Luis Abreu, MD

Associate Professor of Clinical Urology and Radiology

Image of Andre Luis Abreu, MD
Is this your profile? Click to edit

Publications

  • Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0. Radiology 2025;315:e24014. Eur Urol. 2025 Nov; 88(5):e101-e102.. View in PubMed
  • Salvage treatments after focal therapy for prostate cancer – a comprehensive review. Prostate Cancer Prostatic Dis. 2025 Sep; 28(3):557-571.. View in PubMed
  • The learning curve for transperineal MRI/TRUS fusion prostate biopsy: A prospective evaluation of a stepwise approach. Urol Oncol. 2025 01; 43(1):64.e1-64.e10.. View in PubMed
  • The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics. Urol Clin North Am. 2024 Feb; 51(1):1-13.. View in PubMed
  • Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Sci Rep. 2023 08 18; 13(1):13457.. View in PubMed
  • Focal Therapy for Prostate Cancer: Getting Ready for Prime Time. Eur Urol. 2022 01; 81(1):34-36.. View in PubMed
  • Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up. World J Urol. 2021 Sep; 39(9):3295-3307.. View in PubMed
  • Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy. Curr Urol Rep. 2021 Mar 22; 22(4):27.. View in PubMed
  • The Pillars for Sustained Growth of Magnetic Resonance Imaging Pathway for Prostate Cancer Diagnosis: Quality, Reproducibility, Accessibility, Cost Effectiveness, and Training. Eur Urol. 2020 04; 77(4):491-493.. View in PubMed
  • One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis. World J Urol. 2020 Apr; 38(4):949-956.. View in PubMed
  • Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up. Eur Urol. 2019 02; 75(2):208-214.. View in PubMed
  • Contrast-Enhanced Transrectal Ultrasound in Focal Therapy for Prostate Cancer. Curr Urol Rep. 2018 Aug 28; 19(10):87.. View in PubMed